PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2

Abstract Breast cancer is the most common cancer type among women worldwide. The majority of breast cancer expresses estrogen receptor (ER) and endocrine therapy is a standard treatment of ER-positive breast cancer. However, development of the therapy resistance is still a major challenge and thus n...

Full description

Bibliographic Details
Main Authors: Toshihiko Takeiwa, Kazuhiro Ikeda, Takashi Suzuki, Wataru Sato, Kaori Iino, Yuichi Mitobe, Hidetaka Kawabata, Kuniko Horie, Satoshi Inoue
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-13601-7